ZYME
Zymeworks Inc.
NASDAQ · Healthcare · Biotechnology · CA
$26.57
−3.31%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $2.44
- Revenue estimate
- $233.7M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.62
- EPS estimate
- -$0.56
- Revenue actual
- $4.6M
- Revenue estimate
- $4.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -95.3%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $39
- PT range
- $32 – $55
- Analysts
- 8
8 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.56 | -$0.62 | Miss -10.32% | $4.6M |
| May 7, 2026 | -$0.10 | -$0.59 | Miss -490.00% | $2.4M |
| Nov 6, 2025 | -$0.30 | -$0.26 | Beat 13.33% | $27.6M |
| Aug 7, 2025 | -$0.52 | $0.03 | Beat 105.77% | $48.7M |
| May 8, 2025 | -$0.45 | -$0.30 | Beat 33.33% | $27.1M |
| Mar 5, 2025 | $0.01 | -$0.31 | Miss -3200.00% | $31.0M |
| Oct 31, 2024 | -$0.40 | -$0.39 | Beat 2.50% | $16.0M |
| Aug 1, 2024 | -$0.42 | -$0.49 | Miss -17.37% | $19.2M |
| May 2, 2024 | -$0.31 | -$0.42 | Miss -35.48% | $10.0M |
| Mar 6, 2024 | -$0.39 | -$0.20 | Beat 48.72% | $16.9M |
| Aug 10, 2023 | -$0.51 | -$0.76 | Miss -49.02% | $7.0M |
| Mar 7, 2023 | $4.84 | $4.65 | Miss -3.93% | $402.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026